Prolonged DAPT After Stenting Yields Similar Ischemic, Bleeding Risks in Women, Men
In a secondary analysis of the dual antiplatelet therapy (DAPT) study, late risk for ischemic and bleeding events was similar in women and men who received prolonged dual antiplatelet therapy beyond one year after coronary stenting. Natalia C. Berry, MD, interventional cardiology specialist at Brigham and Women's Hospital and instructor in medicine at Harvard Medical School, and fellow researchers for the DAPT study performed the secondary analysis to determine whether risks and benefits of prolonged dual antiplatelet therapy are different among women and men.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063